Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Multifunctional metasurface lens for imaging and Fourier transform.

Wen D, Yue F, Ardron M, Chen X.

Sci Rep. 2016 Jun 8;6:27628. doi: 10.1038/srep27628.

2.

Weekend specialist intensity and admission mortality in acute hospital trusts in England: a cross-sectional study.

Aldridge C, Bion J, Boyal A, Chen YF, Clancy M, Evans T, Girling A, Lord J, Mannion R, Rees P, Roseveare C, Rudge G, Sun J, Tarrant C, Temple M, Watson S, Lilford R; HiSLAC Collaborative.

Lancet. 2016 Jul 9;388(10040):178-86. doi: 10.1016/S0140-6736(16)30442-1. Epub 2016 May 10.

3.

Direct CO(2) laser-based generation of holographic structures on the surface of glass.

Wlodarczyk KL, Weston NJ, Ardron M, Hand DP.

Opt Express. 2016 Jan 25;24(2):1447-62. doi: 10.1364/OE.24.001447.

PMID:
26832525
4.

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.

Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9.

5.

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A.

Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Erratum in: Lancet. 2012 Aug 25;380(9843):730.

6.

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group.

Trials. 2011 Nov 30;12:252. doi: 10.1186/1745-6215-12-252.

7.

A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT).

Teal P, Davis S, Hacke W, Kaste M, Lyden PD; Modified Randomized Exposure Controlled Trial Study Investigators, Fierus M; Bayer HealthCare AG.

Stroke. 2009 Nov;40(11):3518-25. doi: 10.1161/STROKEAHA.109.551382. Epub 2009 Sep 10.

8.

Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3).

SCOPE (Stroke Complications and Outcomes Prediction Engine) Collaborations; IST, Lewis SC, Sandercock PA, Dennis MS.

J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):397-400. Epub 2007 Aug 31.

PMID:
17766429
9.

Simulect induction significantly decreases CMV infection in kidney recipients compared to OKT3.

Kode RK, Kumar AM, Pankewycz O, Damask AM, Seirka D, Lam A, Phillips K, Ardron M, Brezin J, Chvala R, Kumar MS.

Transplant Proc. 2001 Feb-Mar;33(1-2):1268-9. No abstract available.

PMID:
11267286
10.

Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients: a dose-ranging study.

Lees KR, Dyker AG, Sharma A, Ford GA, Ardron ME, Grosset DG.

Stroke. 2001 Feb;32(2):466-72. Erratum in: Stroke 2001 Dec 1;32(12):2961.

11.

The 1996 Leicestershire Community Stroke & Ethnicity Study: differences and similarities between South Asian and white strokes.

Hsu RT, Ardron ME, Brooks W, Cherry D, Taub NA, Botha JL.

Int J Epidemiol. 1999 Oct;28(5):853-8.

PMID:
10597982
12.

Impaired dexterity of the ipsilateral hand after stroke and the relationship to cognitive deficit.

Sunderland A, Bowers MP, Sluman SM, Wilcock DJ, Ardron ME.

Stroke. 1999 May;30(5):949-55.

13.

Band neutrophil counts are unnecessary for the diagnosis of infection in patients with normal total leukocyte counts.

Ardron MJ, Westengard JC, Dutcher TF.

Am J Clin Pathol. 1994 Nov;102(5):646-9.

PMID:
7942630
14.

Microvascular skin responses in elderly people with varicose leg ulcers.

Ardron ME, Helme RD, McKernan S.

Age Ageing. 1991 Mar;20(2):124-8.

PMID:
2053501
15.

Assessment apartments for elderly patients.

Ardron M.

Nurs Times. 1990 Aug 8-14;86(32):52. No abstract available.

PMID:
2385515
16.

Management of constipation.

Ardron ME, Main AN.

BMJ. 1990 May 26;300(6736):1400. No abstract available.

17.

Use of rehabilitation apartments for elderly patients.

Ardron ME, Finneston A.

Age Ageing. 1990 May;19(3):195-8.

PMID:
2363381
18.

The destination and dependency of patients discharged from care of the elderly units in the West Midlands.

Turner G, Sandler M, Lodwick R, Chellingsworth M, Ardron M, Briggs J, Grimmer M, Steel A, Swain D, Wallis P.

Health Trends. 1990-1991;22(4):158-60.

PMID:
10128626
19.

Urinary excretion of albumin, alpha-1-microglobulin, and N-acetyl-B-D-glucosaminidase in relation to smoking habits in diabetic and nondiabetic subjects.

Ardron M, Macfarlane IA, Martin P, Walton C, Day J, Robinson C, Calverly P.

J Diabet Complications. 1989 Jul-Sep;3(3):154-7.

PMID:
2476455
20.

Anti-smoking advice for young diabetic smokers: is it a waste of breath?

Ardron M, MacFarlane IA, Robinson C, van Heyningen C, Calverley PM.

Diabet Med. 1988 Oct;5(7):667-70.

PMID:
2975552

Supplemental Content

Loading ...
Support Center